The Technical Network for Strengthening Immunization Services

We are a global network of immunization professionals committed to strengthening immunization services by building relationships, sharing knowledge, coordinating activities, and aligning priorities and goals. Learn More.

Already a member? Log in
  Wednesday, 28 September 2016
  0 Replies
  7.4K Visits
Abstract

Presently the dose of rabies immunoglobulin (RIG) which is an integral part of rabies post exposure prophylaxis (PEP) is calculated based on body weight though the recommendation is to infiltrate the wound(s). This practice demands large quantities of RIG which may be un-affordable to many patients. In this background, we conducted this study to know if the quantity and cost of RIG can be reduced by restricting passive immunization to local infiltration alone and avoiding systemic intramuscular administration based on the available scientific evidence. Two hundred and sixty nine category III patients bitten by suspect or confirmed rabid dogs/ animals were infiltrated with equine rabies immunoglobulin (ERIGs) in and around the wound, the quantity of ERIG used was proportionate to the size and number of wounds irrespective of their body weight. They were followed with a regular course of rabies vaccination by intra-dermal route. As against 363 vials of RIGs required for all these cases as per current recommendation based on body weight, they required only 42 vials of 5ml RIG. Minimum dose of RIGs given was 0.25ml and maximum dose given was 8 ml. On an average 1.26 ml of RIGs was required per patient that costs Rs. 150 ($3). All the patients were followed for 9 months and they were healthy and normal at the end of observation period. With local infiltration, that required small quantities of RIG, the RIGs could be made available to all patients in times of short supply in the market. A total of 30 (11%) serum samples of patients were tested for rabies virus neutralizing antibodies by the rapid fluorescent focus inhibition test (RFFIT) and all showed antibody titers >0.5 IU/mL by day 14. In no case the dose was higher than that required based on body weight and no immunosuppression resulted. To conclude, this pilot study shows that local infiltration of RIG need to be considered in times of non availability in the market or un-affordability by poor patients. This preliminary study needs to be done on larger scale in other centers with long term follow up to substantiate the results of our study.



Read More free now courtesy PMC and Hum Vaccin Immunother. 2016 Mar; 12(3): 837–842. :



https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4964710/pdf/khvi-12-03-1085142.pdf



This would drasticaly reduce costs and make PEP affordable to all in rabid animal bites,


Thanks


Omesh BHaeti, Shimla India


There are no replies made for this post yet.

Our community, our knowledge

6145 members

TechNet members are immunization professionals working to improve immunization services in every country and at all levels from global policy formulation and national programme management all the way to service delivery at subnational levels.

  • Connect with each other and make new contacts
  • Ask questions, provide answers, and share knowledge in our forum
  • Join specialist groups (communities of practice)
  • Track upcoming events, such as webinars, training opportunities and global events
  • Browse key publications on Hot Topics curated by global experts
  • Search for guidance in our Knowledge Hub
wood croud background

Our Partners

We are proud to work with many organizations and initiatives across the world in our efforts to help strengthen immunization services. We support the work of all immunization professionals, from both the public and private sector, from governments and international organizations to NGOs, academic institutions, companies and manufacturers. TechNet is a member of two global immunization partnerships:

Gavi Alliance’s immunization Supply Chain Steering Committee (iSC2)

Bill and Melinda Gates Logo
Clinton logo
GAVI logo
GAVI logo
JSI logo
PATH logo
UNICEF logo
USAID logo
Village Reach logo
WHO logo

Partnership of Immunization Networks

Boost logo
IAPHL logo
IA Watch logo
Geneva Learning Foundation logo